Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations

被引:39
|
作者
Li, Quan [1 ,2 ]
Cao, Zanxia [3 ]
Rahman, Proton [1 ]
机构
[1] Mem Univ, Fac Med, Dept Med, St John, NF, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2020年 / 8卷 / 08期
关键词
angiotensin-converting enzyme 2; COVID-19; ethnic variation; gene expression; molecular dynamics simulation; SARS-CoV-2; GPU NODES; PROTEIN; BANG; ACE2;
D O I
10.1002/mgg3.1344
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background There appears to be large regional variation for susceptibility, severity, and mortality for COVID-19 infections. Numerous potential factors could explain the wide variability in the number of infections and death among the countries. We examined genetic differences in the human angiotensin-converting enzyme 2 (hACE2) gene, as its receptor serves as a cellular entry for SARS-CoV-2. At present, there is a paucity of data regarding the differences for ACE2 polymorphisms and expression levels between ethnicities. Methods We compared the allele frequency of mutations between European and East Asians. Molecular dynamic simulation were performed to investigate the influences of significant mutant on protein structure. The binding free energies were calculated between S protein and hACE2. We also examined hACE2 gene expression in eight global populations from HapMap3. Results Four missense mutations showed significant minor allele frequency difference between Asians and Caucasians. Molecular dynamic demonstrated that two of these variants (K26R and I468V) may affect binding characteristics between S protein of the virus and hACE2 receptor. We also noted marginal differences in gene expression for some populations in HapMap3 as compared to the Chinese population. Conclusion Our studies reveal subtle changes in the genetics of hACE2 between human populations, but the magnitude of the difference was small and the significance is not clear in the absence of further in vitro and functional studies.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Angiotensin-Converting Enzyme 2 SNPs as Common Genetic Loci and Optimal Early Identification Genetic Markers for COVID-19
    Ma, Yan
    Li, Qiuyue
    Chen, Jun
    Liu, Songmei
    Liu, Shanshan
    He, Xiaomeng
    Ling, Yun
    Zheng, Jianghua
    Corpe, Christopher
    Lu, Hongzhou
    Wang, Jin
    PATHOGENS, 2022, 11 (08):
  • [22] Molecular dynamic analyses of the interaction of SARS-CoV-1 or 2 variants with various angiotensin-converting enzyme-2 species
    Aloufi, Abeer S.
    El-Arabey, Amr Ahmed
    Eltayb, Wafa Ali
    Elsayim, Rasha
    Marenga, Hanin S.
    Modafer, Yosra
    Awadalla, Maaweya E.
    Mohapatra, Pranab K.
    Mohapatra, Ranjan K.
    Abdalla, Mohnad
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [23] Angiotensin-Converting Enzyme 2 (SARS-CoV-2 receptor) expression in human skeletal muscle
    Perez-Valera, Mario
    Martinez-Canton, Miriam
    Gallego-Selles, Angel
    Galvan-Alvarez, Victor
    Gelabert-Rebato, Miriam
    Morales-Alamo, David
    Santana, Alfredo
    Martin-Rodriguez, Saul
    Ponce-Gonzalez, Jesus Gustavo
    Larsen, Steen
    Losa-Reyna, Jose
    Perez-Suarez, Ismael
    Dorado, Cecilia
    Curtelin, David
    Gonzalez-Henriquez, Juan Jose
    Boushel, Robert
    Hallen, Jostein
    de Pablos Velasco, Pedro
    Freixinet-Gilart, Jorge
    Holmberg, Hans-Christer
    Helge, Jorn W.
    Martin-Rincon, Marcos
    Calbet, Jose A. L.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2021, 31 (12) : 2249 - 2258
  • [24] Human angiotensin-converting enzyme 2-specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants
    Lu, Tong
    Zhang, Chengcheng
    Li, Zhengqi
    Wei, Vi
    Sadewasser, Anne
    Yan, Yan
    Sun, Lin
    Li, Jian
    Wen, Vihui
    Lai, Shimin
    Chen, Changhui
    Zhong, Hua
    Jime, Marta Reyes
    Klar, Richard
    Schell, Monika
    Raith, Stefanie
    Michel, Sven
    Ke, Bixia
    Zheng, Huanying
    Jaschinski, Frank
    Zhang, Nan
    Xiao, Haipeng
    Bachert, Claus
    Wen, Weiping
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (04) : 1044 - 1059
  • [25] SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
    Felber, Randy
    New, William
    Riskin, Suzanne I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [26] Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
    Mitani, Sawane
    Yabuki, Akira
    Sawa, Mariko
    Chang, Hye-Sook
    Yamato, Osamu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2014, 76 (01) : 45 - 50
  • [27] Urinary angiotensin-converting enzyme 2 in patients with CKD
    Mizuiri, Sonoo
    Aoki, Toshiyuki
    Hemmi, Hiromichi
    Arita, Michitsune
    Sakai, Ken
    Aikawa, Atsushi
    NEPHROLOGY, 2011, 16 (06) : 567 - 572
  • [28] Angiotensin-converting enzyme 2 polymorphisms and cardiovascular risk
    Grace, J. A.
    Burrell, L. M.
    Patel, S. K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (10) : 1167 - 1167
  • [29] Vascular Angiotensin-Converting Enzyme 2 Lord of the Ring?
    Batlle, Daniel
    Wysocki, Jan
    Khan, Mirza S.
    CIRCULATION RESEARCH, 2010, 107 (07) : 822 - 824
  • [30] Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
    Edmonston, Daniel L.
    South, Andrew M.
    Sparks, Matthew A.
    Cohen, Jordana B.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (05) : 404 - 411